You're here : Home What is glaucoma?
article thumbnailMIgraine and glaucoma

Migraine and glaucoma can sometimes be associated. Typically, most people who have experienced migraine are at a low risk of developing...
+ more info

article thumbnailPrimary angle closure glaucoma

CAUSE & SYMPTOMS Primary angle closure glaucoma (‘’narrow or closed angle glaucoma’’) is the less common of the two major...
+ more info

Other Articles
New agents for treating glaucoma: Latanoprostene bunod PDF Print E-mail
Written by Administrator   
Friday, 04 October 2013 10:53

Latanoprostene bunod is a novel compound containing a PG analogue and Nitric Oxide. It appears to offer about 1mmHg further lowering of IOP versus latanoprost, and is a well tolerated medication in early studies; data has been presented at ARVO in 2013. Nitrous oxide has been shown to relax the ciliary muscle and trabecular meshwork, possibly therefore having a combined method of action with enhanced trabecular outflow, and also increased uveoscleral outflow.

Therefore, at this stage, this new medication is likely judged to offer a small but significant advance in treatment, and its release hopefully in the next year or two is anticipated with optimism.

Bunod image

Glaucoma Medications

Last Updated on Monday, 07 October 2013 23:31